Night eating syndrome: Implications for severe obesity

Department of Obesity & Endocrinology, University of Liverpool, Liverpool, UK.
Nutrition & Diabetes (Impact Factor: 2.65). 09/2012; 2(9):e44. DOI: 10.1038/nutd.2012.16
Source: PubMed


Night eating syndrome (NES) was first identified in 1955 by Stunkard, a psychiatrist specialising in eating disorders (ED). Over the last 20 years considerable progress has been made in defining NES as a significant clinical entity in its own right and it has now been accepted for inclusion in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) due for publication in 2013. NES is considered a dysfunction of circadian rhythm with a disassociation between eating and sleeping. Core criteria include a daily pattern of eating with a significantly increased intake in the evening and/or night time, as manifested by one or both of the following: at least 25% of food intake is consumed after the evening meal or at least two episodes of nocturnal eating per week. An important recent addition to core criteria includes the presence of significant distress and/or impairment in functioning. Stunkard's team recommend further investigation on the pathogenesis of NES, in particular its relationship with traumatic life events, psychiatric comorbidity, the age of onset of NES and course of NES over time. The relationship between NES and other ED also requires further clarification as night-eaters exhibit some features of other ED; previous guidance to separate NES from other ED may have hindered earlier characterisation of NES. Evidence from European and American studies suggests NES features strongly in populations with severe obesity. The complex interplay between depression, impaired sleep and obesity-related comorbidity in severely obese individuals makes understanding NES in this context even more difficult. This review examines evidence to date on the characterisation of NES and concludes by examining the applicability of current NES criteria to individuals with severe obesity.

Download full-text


Available from: Janice Abbott, Feb 24, 2014
  • Source
    • "The impact of NES on daily functioning is of current research interest [13]; in particular, its impact on the pathogenesis and maintenance of impaired sleep in severe obesity and obesity-related comorbidity is unclear. Eating and sleep behavior in obese NES populations often are studied in isolation, without consideration of their interrelationships [15]. Our cross-sectional study sought to explore these associations using validated tools to measure sleep quality using the Pittsburgh Sleep Quality Index (PSQI) [16], EDS (as a surrogate marker for suspected OSA) using the Epworth Sleepiness Scale (ESS) [17], and night-eating behavior using the Night Eating Questionnaire (NEQ) [18].The primary objective of our study was to identify the prevalence of poor sleep quality, EDS, and night-eating behavior in consecutive patients with severe obesity attending a Specialist Weight Management Service based in Liverpool, United Kingdom. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The relationships between night eating, poor sleep quality, and obesity-related comorbidity in a severely obese UK clinic population is unknown. We used validated tools to identify prevalence and to explore this relationship. Consecutive consenting clinic attendees completed the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Score (ESS), and Night Eating Questionnaire (NEQ) to identify sleep quality, excessive daytime sleepiness (EDS) (a surrogate marker for suspected obstructive sleep apnea [OSA]), and night eating, respectively. Proportions of individuals above and below tool cutoff points were compared. Pearson product moment correlation coefficients examined relationships between total scores. Reported prevalence from 144 participants (mean body mass index [BMI] 46.9 [9.5]kg/m(2); age 44.6 [12.1]years; 68% women) had poor sleep quality (73.0%), suspected OSA (30.8%), and night-eating behavior (2.8%). The strongest correlation between PSQI and NEQ scores (r=0.54; P<.001) was undiminished after controlling for EDS. Although significantly correlated, PSQI and ESS scores (r=0.31; P<.001) reduced after controlling for night eating (r=0.21; P=.02). Correlation between NEQ and ESS scores (r=0.26; P=.002) was smaller and nonsignificant after controlling for sleep quality (r=0.12; P=.18). Poor sleep quality is common in severe obesity, though night eating is rare. The association between poor sleep quality and night eating is not influenced by the presence of EDS.
    Full-text · Article · Aug 2013 · Sleep Medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: This work is motivated by the growing prevalence of obesity, a health problem affecting over 500 million people. Measurements of energy intake are commonly used for the study and treatment of obesity. However, the most widely used tools rely upon self-report and require a considerable manual effort, leading to underreporting of consumption, non-compliance, and discontinued use over the long term. The purpose of this paper is to describe a new method that uses a watch-like configuration of sensors to continuously track wrist motion throughout the day and automatically detect periods of eating. Our method uses the novel idea that meals tend to be preceded and succeeded by periods of vigorous wrist motion. We describe an algorithm that segments and classifies such periods as eating or non-eating activities. We also evaluate our method on a large data set (43 subjects, 449 total hours of data, containing 116 periods of eating) collected during free-living. Our results show an accuracy of 81% for detecting eating at 1 second resolution in comparison to manually marked event logs of periods eating. These results indicate that vigorous wrist motion is a useful indicator for identifying the boundaries of eating activities, and that our method should prove useful in the continued development of body-worn sensor tools for monitoring energy intake.
    No preview · Article · Sep 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: The increased prevalence and high comorbidity of metabolic syndrome and mental health disorders have prompted investigation into the potential contributing mechanisms. There is a bidirectional association between metabolic syndrome and mental health disorders including schizophrenia, bipolar disorder, depression, anxiety, attention deficit/hyperactivity disorder, and autism spectrum disorders. Medication side effects and social repercussions are contributing environmental factors, but there are a number of shared underlying neurological and physiological mechanisms that explain the high comorbidity between these two disorders. Inflammation is a state shared by both disorders, and it contributes to disruptions of neuroregulatory systems, including the serotonergic, dopaminergic, and neuropeptide Y systems, as well as dysregulation of the hypothalamic-pituitary-adrenal axis. Metabolic syndrome in pregnant women also exposes the developing fetal brain to inflammatory factors that predispose the offspring to metabolic syndrome and mental health disorders. Due to the shared nature of these conditions, treatment should address aspects of both mental health and metabolic disorders. Additionally, interventions need to be developed that can interrupt the transfer of increased risk of the disorders to the next generation. © 2013 S. Karger AG, Basel.
    No preview · Article · Sep 2013 · Neuroendocrinology
Show more